Verrica Pharmaceuticals Statistics

Total Valuation

VRCA has a market cap or net worth of $64.48 million. The enterprise value is $88.64 million.

Market Cap	64.48M
Enterprise Value	88.64M

Important Dates

The next estimated earnings date is Thursday, February 27, 2025, before market open.

Earnings Date	Feb 27, 2025
Ex-Dividend Date	n/a

Share Statistics

VRCA has 90.56 million shares outstanding. The number of shares has increased by 5.62% in one year.

Current Share Class	90.56M
Shares Outstanding	90.56M
Shares Change (YoY)	+5.62%
Shares Change (QoQ)	+0.65%
Owned by Insiders (%)	45.22%
Owned by Institutions (%)	8.93%
Float	43.13M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.60
Forward PS	4.83
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	9.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.34

Current Ratio	1.34
Quick Ratio	1.10
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.93

Financial Efficiency

Return on equity (ROE) is -2,059.89% and return on invested capital (ROIC) is -93.65%.

Return on Equity (ROE)	-2,059.89%
Return on Assets (ROA)	-71.41%
Return on Capital (ROIC)	-93.65%
Revenue Per Employee	$92,100
Profits Per Employee	-$849,910
Employee Count	100
Asset Turnover	0.14
Inventory Turnover	15.84

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -87.95% in the last 52 weeks. The beta is 1.49, so VRCA's price volatility has been higher than the market average.

Beta (5Y)	1.49
52-Week Price Change	-87.95%
50-Day Moving Average	0.83
200-Day Moving Average	4.16
Relative Strength Index (RSI)	45.97
Average Volume (20 Days)	630,213

Short Selling Information

The latest short interest is 1.95 million, so 2.15% of the outstanding shares have been sold short.

Short Interest	1.95M
Short Previous Month	2.00M
Short % of Shares Out	2.15%
Short % of Float	4.52%
Short Ratio (days to cover)	2.65

Income Statement

In the last 12 months, VRCA had revenue of $9.21 million and -$84.99 million in losses. Loss per share was -$1.83.

Revenue	9.21M
Gross Profit	-13.47M
Operating Income	-74.31M
Pretax Income	-80.74M
Net Income	-84.99M
EBITDA	-73.39M
EBIT	-74.31M
Loss Per Share	-$1.83

Full Income Statement

Balance Sheet

The company has $22.96 million in cash and $47.11 million in debt, giving a net cash position of -$24.15 million or -$0.27 per share.

Cash & Cash Equivalents	22.96M
Total Debt	47.11M
Net Cash	-24.15M
Net Cash Per Share	-$0.27
Equity (Book Value)	-34.05M
Book Value Per Share	-0.75
Working Capital	7.16M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$59.37 million and capital expenditures -$254,000, giving a free cash flow of -$59.62 million.

Operating Cash Flow	-59.37M
Capital Expenditures	-254,000
Free Cash Flow	-59.62M
FCF Per Share	-$0.66

Full Cash Flow Statement

Margins

Gross Margin	-146.28%
Operating Margin	-806.82%
Pretax Margin	-922.81%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VRCA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.62%
Shareholder Yield	-5.62%
Earnings Yield	-131.81%
FCF Yield	-92.47%

Analyst Forecast

The average price target for VRCA is $6.00, which is 742.70% higher than the current price. The consensus rating is "Hold".

Price Target	$6.00
Price Target Difference	742.70%
Analyst Consensus	Hold
Analyst Count	5
Revenue Growth Forecast (5Y)	72.61%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

VRCA has an Altman Z-Score of -17.21 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-17.21
Piotroski F-Score	2